Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dyax Corp (NASDAQ:DYAX)

23.69
Delayed Data
As of Aug 28
 -0.20 / -0.84%
Today’s Change
9.19
Today|||52-Week Range
30.55
+68.49%
Year-to-Date

Today’s Trading

Previous close23.89
Today’s open23.67
Day’s range23.06 - 24.52
Volume700,347
Average volume (3 months)941,958
Market cap$3.5B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+65.38%
Earnings growth (this year)-205.56%
Earnings growth (next 5 years)+30.66%
Revenue growth (last year)+51.55%
P/E ratioNM
Price/Sales22.95
Price/Book30.60

Competitors

 Today’s
change
Today’s
% change
CRLCharles River Labora...+0.27+0.39%
PRXLPAREXEL Internationa...-1.73-2.50%
INCRINC Research Holding...-0.08-0.19%
PRAHPRA Health Sciences ...+0.27+0.72%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$81.7M
Annual profit (last year)-$11.9M
Net profit margin-14.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts

Partner Offers